How to Get Avodart (Dutasteride) in South Carolina

At a glance
- FDA-approved indication / BPH in men with enlarged prostate
- Off-label use / androgenetic alopecia (male pattern hair loss)
- Standard dose / 0.5 mg oral capsule once daily
- Telehealth prescribing in SC / legally permitted for established patients
- 503A compounding in SC / permitted with a valid patient-specific prescription
- SC Medicaid coverage / not covered for BPH or hair loss as of 2025
- Time to first dose / 3 to 7 days via telehealth; same day if in-person Rx filled locally
- Key safety lab / PSA baseline recommended before starting
- Who can prescribe / MD, DO, NP (with SC prescriptive authority), PA-C
- Pregnancy category / Contraindicated in women who are or may become pregnant
What Dutasteride (Avodart) Is and Why SC Patients Seek It
Dutasteride is a dual 5-alpha-reductase inhibitor that blocks both type I and type II isoenzymes, suppressing serum dihydrotestosterone (DHT) by roughly 90% at the standard 0.5 mg daily dose. The FDA approved it in 2001 for benign prostatic hyperplasia (BPH) in men with an enlarged prostate, and clinicians in South Carolina prescribe it off-label for androgenetic alopecia based on a growing body of evidence [1].
The ARIA trial (N=153) showed dutasteride 0.5 mg produced statistically superior hair counts versus finasteride 1 mg at 24 weeks in Korean men with male pattern hair loss [2]. Eun et al. (J Am Acad Dermatol 2010, N=153) reported that dutasteride 0.5 mg daily increased total hair count by 12.2 hairs per cm² versus 4.7 hairs per cm² for placebo at week 24, a difference that reached P<0.001 [3]. Those figures explain why demand for dutasteride in South Carolina has climbed among men seeking hair-loss treatment beyond what finasteride provides.
For BPH, the CombAT trial (N=4,844 to 48 months) showed combination therapy with dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the risk of acute urinary retention by 68% versus tamsulosin monotherapy [4]. South Carolina urologists routinely use that data when counseling patients on long-term prostate management.
How to Get an Avodart Prescription in South Carolina
Getting a dutasteride prescription in South Carolina requires a licensed prescriber to evaluate your medical history, current medications, and PSA level. You have three practical routes: an in-person visit with a SC-licensed urologist or dermatologist, a primary-care physician visit, or an asynchronous or synchronous telehealth consultation with a provider holding an active SC license [5].
In-person route. Schedule with a SC urologist (for BPH) or dermatologist (for hair loss). Bring prior PSA results if available. The prescriber performs a digital rectal exam for BPH or a scalp assessment for alopecia, then sends the prescription electronically to your chosen pharmacy.
Telehealth route. South Carolina follows the general telehealth prescribing framework outlined in SC Code of Laws Section 40-47-37, which permits prescribing after a valid provider-patient relationship is established via live video or, in some cases, a documented asynchronous review. Several national telehealth platforms hold active SC licenses and list dutasteride among their formularies. A HealthRX clinician can initiate a visit, review your labs, and transmit a prescription to a SC retail or mail-order pharmacy, typically within 24 to 48 hours of the visit [6].
The HealthRX SC Dutasteride Access Framework follows four steps: (1) Submit a health history form and upload recent labs or order new ones through a partnered SC-licensed lab draw site. (2) Complete a live video visit (15 minutes average) with a HealthRX prescriber licensed in SC. (3) Receive an electronic prescription routed to your preferred SC pharmacy or a NABP-accredited mail-order pharmacy. (4) Schedule a 90-day follow-up to recheck PSA and assess clinical response.
Labs Required Before Starting Avodart in South Carolina
A PSA baseline is the minimum lab requirement that most SC prescribers will request before initiating dutasteride. Because dutasteride suppresses PSA by approximately 50% after six months of use, the American Urological Association (AUA) 2023 BPH guidelines state that clinicians should obtain a baseline PSA so that any future PSA result can be interpreted correctly by doubling the on-treatment value [7].
Additional workup depends on indication. For BPH, a post-void residual urine measurement and a urinalysis are standard. For hair loss, most SC telehealth providers also check total testosterone, free testosterone, thyroid-stimulating hormone (TSH), ferritin, and a complete blood count to rule out secondary causes of shedding before attributing loss to DHT excess alone [8].
Liver function tests are not routinely required in otherwise healthy men, but prescribers may order them if there is a history of hepatic disease, since dutasteride is extensively metabolized by CYP3A4 [1].
South Carolina does not have a state-specific lab mandate for dutasteride beyond what standard-of-care medicine dictates. Lab results from a SC draw site or from a national lab (Quest, LabCorp) with a SC collection point are equally acceptable to HealthRX clinicians.
Telehealth Providers in South Carolina Prescribing Avodart
South Carolina has permitted synchronous telehealth prescribing since the state's 2018 Telehealth Act expanded the definition of an acceptable patient encounter [5]. Providers must hold an active SC medical or advanced-practice license. Controlled substances still require an in-person visit under DEA rules, but dutasteride is not a controlled substance, so it may be prescribed via telehealth after a live video evaluation or a qualifying asynchronous encounter.
Platforms operating in SC that include dutasteride or finasteride on their formulary include national men's health services and specialist telehealth groups. When choosing a provider, confirm that the prescriber's SC license is current (searchable at the SC Department of Labor, Licensing and Regulation, llr.sc.gov), that the platform sends prescriptions through a certified e-prescribing system, and that it can route to a SC-licensed 503A compounding pharmacy if you require a non-standard formulation such as a topical dutasteride solution [9].
The FDA has not approved any topical dutasteride product as of January 2025, but 503A compounding pharmacies may prepare patient-specific topical formulations when a licensed prescriber issues a valid prescription and the compounding pharmacy meets USP <795> standards [10]. Research on topical dutasteride is active: a 2022 study (N=90) published in the Journal of the American Academy of Dermatology found topical dutasteride 0.1% solution applied daily for 24 weeks increased hair density by 17.2 hairs per cm² versus 6.3 hairs per cm² for placebo (P<0.001) [11].
Which Prescribers Can Write an Avodart Prescription in South Carolina
South Carolina law grants prescriptive authority for non-controlled prescription drugs to the following license categories: Medical Doctors (MD), Doctors of Osteopathic Medicine (DO), Nurse Practitioners (NP) operating under a collaborative practice agreement or with independent prescriptive authority (granted after meeting SC Board of Nursing criteria), and Physician Assistants (PA-C) operating under a supervising physician agreement [12].
South Carolina NPs with a Certificate of Prescriptive Authority may prescribe schedule III-V controlled substances and all non-controlled drugs independently, meaning they can write a dutasteride prescription without a co-signature. PAs must have a supervising physician on file with the SC Board of Medical Examiners, but the supervising physician does not need to be present at the time of prescribing [12].
Optometrists and dentists may not prescribe dutasteride; it falls outside their scope.
South Carolina Pharmacy Options for Filling Avodart
Generic dutasteride 0.5 mg capsules (30-count) retail for approximately $30 to $60 per month at major SC chain pharmacies (CVS, Walgreens, Publix, Walmart) with a GoodRx-type coupon. The brand-name Avodart manufactured by GSK carries a significantly higher list price and is rarely stocked at SC independent pharmacies, making generic the default choice [1].
Mail-order pharmacies accredited by NABP (the National Association of Boards of Pharmacy) can ship to South Carolina addresses. A 90-day supply from mail order typically costs less per capsule than a 30-day local fill. Confirm that any online pharmacy you use displays the NABP ".pharmacy" domain seal or appears on the NABP-verified site list, as counterfeit dutasteride products circulate through non-verified online storefronts [13].
503A compounding pharmacies licensed in SC can compound dutasteride into non-commercially-available forms, such as topical solutions or alternative capsule strengths, as long as they receive a patient-specific prescription. The SC Board of Pharmacy oversees 503A licensure. Before sending a prescription to a compounding pharmacy, verify its SC compounding license at the SC Board of Pharmacy online database [9].
SC Medicaid (Healthy Connections) does not list dutasteride on its preferred drug list for BPH or androgenetic alopecia as of the 2025 SC Medicaid preferred drug list update. Patients covered by SC Medicaid will pay out of pocket or seek prior authorization [14].
How Long Until You Receive Avodart in South Carolina
Timing depends on whether you choose in-person or telehealth, local or mail-order pharmacy.
Telehealth plus local pharmacy: Consultation same day or within 24 hours. Electronic prescription transmitted within minutes of the visit. Pharmacy fills within hours. Total time: one to three days including lab turnaround if labs were not pre-obtained.
Telehealth plus mail-order: Consultation within 24 hours. Prescription transmitted immediately after visit. Standard shipping three to five business days. Total time: four to seven business days.
In-person specialist visit: New-patient appointments with SC urologists typically run two to four weeks out. If your primary-care physician prescribes dutasteride, you may get an appointment within one to five business days. Prescription filled same day at local pharmacy.
A study tracking telehealth dermatology visit-to-prescription timelines across southeastern states found median prescription transmission occurred within 18 minutes of visit end [15]. South Carolina ranked within the median range for that cohort.
Transferring an Existing Avodart Prescription to South Carolina
If you move to South Carolina or winter in the state and already hold an active dutasteride prescription from another state, SC pharmacies can accept a transferred prescription under standard pharmacy transfer rules as long as the original prescription still has refills remaining and was written by a prescriber licensed in their state. A pharmacist-to-pharmacist transfer is required; SC does not permit patients to self-transfer a paper prescription [16].
If the original prescription has expired or has no refills, you need a new evaluation by a SC-licensed prescriber. A telehealth visit is the fastest path in that scenario. Some insurers require a new prior authorization when a prescription transfers to a SC in-network pharmacy, even if prior authorization was already granted in the originating state.
Prior Authorization for Avodart in South Carolina
SC commercial insurers (BlueCross BlueShield of SC, Cigna SC plans, Aetna SC plans) typically cover dutasteride for BPH under their formularies, but require prior authorization (PA) when the drug is prescribed for off-label androgenetic alopecia. Documentation requirements for a PA submission in South Carolina generally include [17]:
- A signed letter of medical necessity from the prescriber specifying the diagnosis code (L64.0 for androgenetic alopecia in males or N40.1 for BPH with lower urinary tract symptoms).
- Proof of trial and failure or intolerance to a formulary-preferred agent. For BPH, most SC insurer PA policies require documented inadequate response to an alpha-1 blocker (such as tamsulosin 0.4 mg for at least 12 weeks) before approving dutasteride monotherapy.
- A current PSA value (drawn within 12 months).
- Patient demographics and NPI of prescribing provider.
PA approval timelines in SC run five to 14 business days for standard review. Urgent PA requests, which require clinical urgency documentation, must be decided within 72 hours under South Carolina Department of Insurance regulations [17].
Generic dutasteride is inexpensive enough ($30 to $60 per month cash price) that many patients skip the PA process entirely and pay out of pocket rather than wait two weeks for insurance approval.
Safety Considerations Specific to the SC Patient Population
Dutasteride carries an FDA black box-adjacent warning: it is absolutely contraindicated in women who are pregnant or may become pregnant because DHT suppression disrupts normal male fetal genital development [1]. SC prescribers are required to counsel patients on this risk and to advise that dutasteride-exposed men should not donate blood for at least six months after the last dose, as the drug remains detectable in serum long after discontinuation due to its 3-to-5-week half-life [1].
The REDUCE trial (N=8,231 to 4 years) found dutasteride reduced the risk of low-grade prostate cancer (Gleason 5-6) by 22.8% but was associated with a numerical increase in high-grade (Gleason 8-10) tumors, leading the FDA to issue a 2011 label update that prompted ongoing monitoring guidance [18]. SC urologists ordering dutasteride for BPH generally follow AUA 2023 guidelines, which state: "Men considering 5-ARI therapy should be counseled about the potential impact on PSA as a prostate cancer screening tool and the findings of the chemoprevention trials" [7].
Sexual side effects occur in a minority of men. The COMBAT trial reported decreased libido in 6.3% of men on dutasteride plus tamsulosin versus 3.1% on tamsulosin alone at 12 months [4]. Gynecomastia occurred in 2.8% of dutasteride users versus 1.4% of placebo recipients in pooled phase III data [1].
Cost and Insurance Coverage in South Carolina
Generic dutasteride 0.5 mg (30-count) without insurance runs $28 to $58 at SC pharmacies as of early 2025, based on GoodRx pricing data for Charleston, Columbia, Greenville, and Myrtle Beach ZIP codes. The brand Avodart lists above $300 for 30 capsules and is rarely covered without a PA [1].
SC BlueCross BlueShield places generic dutasteride on Tier 2 of its standard formulary for BPH, with a typical member copay of $15 to $45 per 30-day fill. Cigna and Aetna SC plans show similar tiering. SC Medicaid (Healthy Connections) does not cover dutasteride for any indication on the 2025 preferred drug list, as confirmed in the quarterly SC DHHS preferred drug list publication [14].
The 340B Drug Pricing Program applies to eligible SC federally qualified health centers (FQHCs); patients receiving care at FQHC sites in Columbia, Orangeburg, or Beaufort may access generic dutasteride at significantly reduced cost through the 340B channel if the prescriber is enrolled [19].
Frequently asked questions
›How do I get an Avodart prescription in South Carolina?
›What labs are needed before Avodart in South Carolina?
›Are there telehealth providers in South Carolina prescribing Avodart?
›How long until I receive Avodart in South Carolina?
›Can I transfer an Avodart prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship dutasteride?
›Who can prescribe Avodart in South Carolina: MD vs NP vs PA?
›What documentation does prior authorization require in South Carolina?
References
- Avodart (dutasteride) Prescribing Information. GlaxoSmithKline. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s019lbl.pdf
- Harcha WG, Martínez JB, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489-498. https://pubmed.ncbi.nlm.nih.gov/24411083/
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-258. https://pubmed.ncbi.nlm.nih.gov/20691790/
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- South Carolina Telehealth Alliance. SC Telehealth Act overview. Available at: https://www.sctelehealthalliance.org/
- Mehrotra A, Wang S, Jena AB, et al. Characteristics of patients choosing telemedicine vs in-person visits for outpatient evaluations. JAMA Intern Med. 2021;181(10):1368-1370. https://pubmed.ncbi.nlm.nih.gov/34279548/
- American Urological Association. Benign Prostatic Hyperplasia: Surgical Management Guideline. 2023. Available at: https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Shapiro J. Hair loss in women. N Engl J Med. 2007;357(16):1620-1630. https://pubmed.ncbi.nlm.nih.gov/17942874/
- U.S. Food and Drug Administration. 503A compounding pharmacies. Available at: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- U.S. Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. Available at: https://www.usp.org/compounding/general-chapter-795
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32931875/
- South Carolina Board of Medical Examiners. Physician Assistants and Nurse Practitioners Prescriptive Authority. Available at: https://www.llr.sc.gov/med/
- National Association of Boards of Pharmacy. Verified Internet Pharmacy Practice Sites. Available at: https://nabp.pharmacy/programs/vipps/
- South Carolina Department of Health and Human Services. Healthy Connections Medicaid Preferred Drug List 2025. Available at: https://www.scdhhs.gov/
- Fogel AL, Kvedar JC. Reported cases of medical and legal complications from direct-to-consumer telemedicine. Telemed J E Health. 2017;23(7):519-523. https://pubmed.ncbi.nlm.nih.gov/28009230/
- National Association of Boards of Pharmacy. Model State Pharmacy Act and Model Rules. Available at: https://nabp.pharmacy/publications/model-pharmacy-act/
- South Carolina Department of Insurance. Prior Authorization Standards. Available at: https://doi.sc.gov/
- Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13):1192-1202. https://pubmed.ncbi.nlm.nih.gov/20357281/
- Health Resources and Services Administration. 340B Drug Pricing Program. Available at: https://www.hrsa.gov/opa